Exports In 2020, United States exported $1.63B in Special Pharmaceuticals, making it the 2nd largest exporter of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 151st most exported product in United States. The main destination of Special Pharmaceuticals exports from United States are: Japan ($249M), China ($206M), Belgium ($199M), Singapore ($194M), and Canada ($105M).
The fastest growing export markets for Special Pharmaceuticals of United States between 2019 and 2020 were China ($8.72M), Afghanistan ($7.9M), and Kuwait ($5.57M).
Imports In 2020, United States imported $2.5B in Special Pharmaceuticals, becoming the 1st largest importer of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 163rd most imported product in United States. United States imports Special Pharmaceuticals primarily from: Finland ($509M), Germany ($277M), Switzerland ($226M), Italy ($220M), and Canada ($181M).
The fastest growing import markets in Special Pharmaceuticals for United States between 2019 and 2020 were Italy ($94.1M), Belgium ($79.7M), and Netherlands ($64.4M).
Tariffs In 2018, the average tariff for United States in Special Pharmaceuticals was 0.62%. The countries with the highest import tariffs for Special Pharmaceuticals were North Korea (Most Favoured Nation duty rate treatement, 1.15%), Cuba (Most Favoured Nation duty rate treatement, 1.15%), Algeria (Most Favoured Nation duty rate treatement, 0.92%), Egypt (Most Favoured Nation duty rate treatement, 0.92%), and Eritrea (Most Favoured Nation duty rate treatement, 0.92%).